Here are four things to know:
1. Selective elimination of senescent cells with the drug may delay, prevent or reverse osteoarthritis’ progression.
2. The researchers found senescent cells create the inflammatory molecules which drive osteoarthritis.
3. Researchers used a senolytic molecule called UBX0101 to slow osteoarthritis’ progression in mice.
4. Results included slowed progression of the disease, reduced pain and better cartilage production.
More articles on orthopedics:
How do revision ACL reconstruction patients fare down the road? 4 observations
Orthopedic surgeon to know: Dr. Michael Kiehn of Orthopedic Association
Dr. Mayo Noerdlinger named Top Doc — 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
